1. COVID-19 related substance use services policy changes: Policymaker perspectives on policy developmentimplementation
- Author
-
Brandy F. Henry, Frances R. Levin, Harold Alan Pincus, Jessica K. Johnson, Timothy Hunt, Nabila El-Bassel, Elwin Wu, Michael Chaple, Amar Mandavia, Aimee N.C. Campbell, Caroline A. Arout, Edward V. Nunes, and Pat Lincourt
- Subjects
Distancing ,Substance-Related Disorders ,Best practice ,030508 substance abuse ,Medicine (miscellaneous) ,Stigma (botany) ,03 medical and health sciences ,0302 clinical medicine ,Health care ,Pandemic ,Humans ,030212 general & internal medicine ,Policy Making ,Pandemics ,Service (business) ,Harm reduction ,Public economics ,business.industry ,SARS-CoV-2 ,COVID-19 ,Psychiatry and Mental health ,Clinical Psychology ,Policy ,Pshychiatric Mental Health ,0305 other medical science ,business ,Criminal justice - Abstract
Introduction Due to the COVID-19 pandemic, regulations for substance use services changed to accommodate stay-at-home orders and physical distancing guidelines. Methods Using in-depth interviews (N = 14) and framework analysis, we describe how policymakers developed, adopted, and implemented regulations governing services for substance use disorders during COVID-19, and how policymakers' perceived the impacts of these regulations in New York State. Results During the COVID-19 pandemic, policymakers shifted to more inclusive approaches of knowledge generation and co-production of recommendations. Barriers to adoption and implementation of new regulations included medication/services supply, lack of integration, stigma, and overcriminalization. Conclusion Findings from this study highlight the potential feasibility and benefits of co-produced policies for substance use services and the need for consistent service supply, better integration with health care services, reduced stigma, improved funding structures, best practice guidelines, criminal justice reform, and harm reduction support. These considerations should inform future policy maintenance and modifications to substance use services related to COVID-19.
- Published
- 2021